TuHURA Biosciences HURA
NASDAQ HURA
$1.45 -0.07 (-4.60%)
As of: Nov 12, 2026 · 9:42 AM EST

TuHURA Biosciences (HURA) Return on Assets [ROA] (2011 - 2026)

Updated

TuHURA Biosciences (HURA) reported Return on Assets [ROA] of -8.02% for FY2012, up 248.92 percentage points from -256.94% in FY2011.

Analysis

TuHURA Biosciences (HURA) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

  • According to Business Quant data, Return on Assets [ROA] came in at -256.94% in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 TuHURA Biosciences 96.16 Mn 82.54 Mn - -103,485.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -103,485.40%
Mar 31, 2026 -111,455.30%
Dec 31, 2025 -119,872.97%
Sep 30, 2025 -96.50%
Jun 30, 2025 -110.77%
Mar 31, 2025 -128.82%
Sep 30, 2024 -265.93%
Jun 30, 2024 -115.06%
Mar 31, 2024 -21.75%
Sep 30, 2015 165.75%
Jun 30, 2015 145.20%
Mar 31, 2015 192.18%
Dec 31, 2014 149.87%
Sep 30, 2014 -29.62%
Mar 31, 2014 471.75%
Dec 31, 2013 478.77%
Sep 30, 2013 375.68%
Jun 30, 2013 410.42%
Mar 31, 2013 187.83%
Dec 31, 2012 -461.98%
API Access

TuHURA Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=HURA&period=max&api_key=YOUR_API_KEY